Template:Ergotamine: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(5 intermediate revisions by the same user not shown)
Line 4: Line 4:
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | ERGOMAR (ergotamine tartrate) tablet<sup>®</sup> FDA Package Insert
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | ERGOMAR (ergotamine tartrate) tablet<sup>®</sup> FDA Package Insert
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine indications and usage|Indications and Usage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet indications and usage|Indications and Usage]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine dosage and administration|Dosage and Administration]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet dosage and administration|Dosage and Administration]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine dosage forms and strengths|Dosage Forms and Strengths]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet dosage forms and strengths|Dosage Forms and Strengths]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine contraindications|Contraindications]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet contraindications|Contraindications]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine warnings and precautions|Warnings and Precautions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet warnings and precautions|Warnings and Precautions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine adverse reactions|Adverse Reactions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet adverse reactions|Adverse Reactions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine drug interactions|Drug Interactions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet drug interactions|Drug Interactions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine use in specific populations|Use in Specific Populations]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet use in specific populations|Use in Specific Populations]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine overdosage|Overdosage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet overdosage|Overdosage]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine description|Description]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet description|Description]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine clinical pharmacology|Clinical Pharmacology]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet clinical pharmacology|Clinical Pharmacology]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine nonclinical toxicology|Nonclinical Toxicology]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet nonclinical toxicology|Nonclinical Toxicology]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine clinical studies|Clinical Studies]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet clinical studies|Clinical Studies]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine how supplied storage and handling|How Supplied/Storage and Handling]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet how supplied storage and handling|How Supplied/Storage and Handling]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine patient counseling information|Patient Counseling Information]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet patient counseling information|Patient Counseling Information]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine labels and packages|Labels and Packages]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet labels and packages|Labels and Packages]]
|-
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Ergotamine
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Medihaler ergotamine (ergotamine tartrate)  aerosol, metered<sup>®</sup> FDA Package Insert
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered indications and usage|Indications and Usage]]
|-style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Ergotamine|{{fontcolor|#6C7B8B|Ergotamine}}]]'''''
|-
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Medihaler ergotamine (ergotamine tartrate)  aerosol, metered [3M Riker] <sup>®</sup> FDA Package Insert
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered dosage and administration|Dosage and Administration]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine indications and usage|Indications and Usage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered dosage forms and strengths|Dosage Forms and Strengths]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine dosage and administration|Dosage and Administration]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered contraindications|Contraindications]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine dosage forms and strengths|Dosage Forms and Strengths]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered warnings and precautions|Warnings and Precautions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine contraindications|Contraindications]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered adverse reactions|Adverse Reactions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine warnings and precautions|Warnings and Precautions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered drug interactions|Drug Interactions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine adverse reactions|Adverse Reactions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered use in specific populations|Use in Specific Populations]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine drug interactions|Drug Interactions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered overdosage|Overdosage]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine use in specific populations|Use in Specific Populations]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered description|Description]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine overdosage|Overdosage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered clinical pharmacology|Clinical Pharmacology]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine description|Description]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered nonclinical toxicology|Nonclinical Toxicology]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine clinical pharmacology|Clinical Pharmacology]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered clinical studies|Clinical Studies]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine nonclinical toxicology|Nonclinical Toxicology]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered how supplied storage and handling|How Supplied/Storage and Handling]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine clinical studies|Clinical Studies]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered patient counseling information|Patient Counseling Information]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine how supplied storage and handling|How Supplied/Storage and Handling]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered labels and packages|Labels and Packages]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine patient counseling information|Patient Counseling Information]]
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Medihaler ergotamine (ergotamine tartrate)  aerosol, metered
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine labels and packages|Labels and Packages]]
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Ergotamine
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov]
|-
|-
|}
|}

Latest revision as of 22:59, 11 February 2014

Ergotamine
ERGOMAR (ergotamine tartrate) tablet® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Medihaler ergotamine (ergotamine tartrate) aerosol, metered® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Medihaler ergotamine (ergotamine tartrate) aerosol, metered
ClinicalTrials.gov
Retrieved from "https://www.wikidoc.org/index.php?title=Template:Ergotamine&oldid=942533"